Bullfrog AI Holdings, Inc. is a biotechnology company that leverages advanced artificial intelligence and machine learning technologies to accelerate drug discovery and development processes
By integrating cutting-edge computational methods with vast biomedical data, the company aims to identify and optimize therapeutic candidates more efficiently and effectively. This innovative approach seeks to enhance decision-making in clinical trials and ultimately bring new treatments to market faster, addressing critical unmet medical needs.
Shares of C.H. Robinson Worldwide, Inc. (NASDAQCHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to 15,529.84. The S&P 500 also rose, gaining, 0.19% to 4,900.27.
Shares of Panbela Therapeutics, Inc. (NASDAQPBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P 500 also rose, gaining, 0.02% to 4,891.83.
Shares of CommScope Holding Company, Inc. (NASDAQCOMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2. CommScope shares dipped 6.9% to $2.2150 on Monday.
Shares of TransCode Therapeutics, Inc. (NASDAQRNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
